Robert Marcus
Consultant Haematologist
Addenbrooke's Hospital
Cambridge
CB2 2QQ
UK
Name/email consistency: high
- The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus, R., Hagenbeek, A. Eur. J. Haematol. Suppl (2007)
- Use of rituximab in patients with follicular lymphoma. Marcus, R. Clin. Oncol. (R. Coll. Radiol) (2007)
- Should you tell patients about beneficial treatments that they cannot have? Yes. Marcus, R. BMJ (2007)
- Pathogenesis of MALT lymphoma: implications for risk stratification and therapy. Marcus, R. Leuk. Lymphoma (2007)
- CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., Solal-Celigny, P., Offner, F., Walewski, J., Raposo, J., Jack, A., Smith, P. Blood (2005)
- Current treatment options in aggressive lymphoma. Marcus, R. Leuk. Lymphoma (2003)